Astrana Health (ASTH) Stock Price Target 2026

The average analyst price target for Astrana Health is $50.25, 52.1% above the current price. Of 11 analysts, 11 rate it Buy. Targets range from $37 to $65. The latest change came on Nov 6, 2026, when Needham raised its price target on Astrana Health from $41 to $45 and kept a Buy rating.

The Average Analyst Price Target for Astrana Health is $50.25.

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

11Buy

Consensus RatingBuy# Analysts11Avg. Consensus PT$50.25Upside to Avg. PT+52.1%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Astrana Health Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Needham	Matthew Shea	PT Raise	Buy	$41→$45
Oct 1, 2026	Freedom Capital Markets	Gene Mannheimer	Maintained	Buy	$50
Sep 15, 2026	Oppenheimer	Michael Wiederhorn	Initiate	Outperform	$53
Aug 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$47→$55
Aug 7, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$50→$53
Jul 14, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$45→$50
Jul 14, 2026	BTIG	David Joyce	PT Raise	Buy	$50→$65
Jun 2, 2026	BTIG	David Larsen	Maintained	Buy	$50
May 26, 2026	Barclays	Andrew Mok	Upgrade	Equal-Weight→Overweight	$37→$50
May 14, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$38→$47
May 12, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$35→$45
May 11, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$26→$37
May 8, 2026	BTIG	David Larsen	PT Raise	Buy	$40→$50
May 8, 2026	Needham	Matthew Shea	PT Raise	Buy	$30→$41
Apr 15, 2026	Baird	Michael Ha	PT Raise	Outperform	$37→$40
Mar 13, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$37→$38
Feb 2, 2026	BTIG	David Larsen	PT Cut	Buy	$45→$40
Dec 12, 2025	Needham	Matthew Shea	Initiate	Buy	$28
Nov 25, 2025	Jefferies	Jack Slevin	PT Cut	Buy	$44→$37
Nov 24, 2025	Barclays	Andrew Mok	PT Cut	Equal-Weight	$36→$26